SUN PHARMACEUTICAL INDUSTRIES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,525 INR | +1.23% |
|
+0.92% | +21.09% |
| 05-09 | India's Alembic Pharma posts higher Q4 profit on strong N.America sales | RE |
| 05-08 | Sun Pharmaceutical Industries Limited Receives an Order Passed by Joint Commissioner Secunderabad, Telangana | CI |
ETFs positioned on Sun Pharmaceutical Industries Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.72% | 6 M€ | +6.07% | - | |
| 0.42% | 19 M€ | +7.12% | ||
| 0.20% | 454 M€ | +8.01% | - | |
| 0.20% | 2,867 M€ | +9.57% | - | |
| 0.20% | 153 M€ | +5.91% | - | |
| 0.20% | 1 M€ | +3.49% | - | |
| 0.20% | 3 M€ | -.--% | - | |
| 0.17% | 4 M€ | -4.41% | - | |
| 0.13% | 112 M€ | +4.15% | - | |
| 0.11% | 11 M€ | +5.79% | ||
| 0.08% | 32 M€ | +7.59% | - | |
| 0.05% | 0 M€ | 0.00% | - | |
| 0.05% | 7 M€ | +4.81% | - | |
| 0.05% | 9 M€ | +27.01% | - | |
| 0.03% | 15 M€ | +15.41% | ||
| 0.03% | 45 M€ | 0.00% | - | |
| 0.02% | 34 M€ | +3.43% | - | |
| 0.02% | 34 M€ | +8.24% | - | |
| 0.02% | 391 M€ | +8.67% | - | |
| 0.02% | 39 M€ | +5.63% | - | |
| 0.02% | 306 M€ | +5.68% | - | |
| 0.01% | 105 M€ | +3.54% | - | |
| 0.01% | 14 M€ | -4.28% | ||
| 0.01% | 17 M€ | +2.80% | - |
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows:
- generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment;
- other (6%) : primarily active pharmaceutical ingredients.
At the end of March 2021, the group had 44 production plants worldwide.
Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Sector
Pharmaceuticals
Calendar
2024-05-23
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
1,525
INR
Average target price
1,574
INR
Spread / Average Target
+3.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +21.09% | 43.27B | |
| +25.28% | 22.92B | |
| +19.22% | 15.43B | |
| +13.51% | 12.95B | |
| +44.01% | 11.83B | |
| -7.79% | 6.91B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.02% | 5.55B | |
| +9.14% | 4.9B |
- Stock Market
- Equities
- SUNPHARMA Stock
- Funds and ETFs Sun Pharmaceutical Industries Ltd.
